347 related articles for article (PubMed ID: 20852369)
1. Effect of levamisole in steroid-dependent nephrotic syndrome.
Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
[TBL] [Abstract][Full Text] [Related]
2. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
[TBL] [Abstract][Full Text] [Related]
3. Levamisole treatment in steroid sensitive nephrotic syndrome.
Alshaya HO; Kari JA
Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
[TBL] [Abstract][Full Text] [Related]
4. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
Alsaran K; Grisaru S; Stephens D; Arbus G
Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
[TBL] [Abstract][Full Text] [Related]
5. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
6. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
Hafeez F; Ahmed TM; Samina U
J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
Ksiazek J; Kryński J
Pediatr Pol; 1995 Dec; 70(12):1037-42. PubMed ID: 8649943
[TBL] [Abstract][Full Text] [Related]
8. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
Meregalli P; Bianchetti MG; Imoberdorf G; Lütschg J; Reymond D; Oetliker OH
Schweiz Med Wochenschr; 1994 May; 124(19):801-5. PubMed ID: 8209202
[TBL] [Abstract][Full Text] [Related]
9. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
[TBL] [Abstract][Full Text] [Related]
10. Levamisole in children's idiopathic nephrotic syndrome.
La Manna A; Polito C; Del Gado R; Foglia AC
Child Nephrol Urol; 1988-1989; 9(4):200-2. PubMed ID: 3255483
[TBL] [Abstract][Full Text] [Related]
11. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
Fu LS; Shien CY; Chi CS
Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
Sümegi V; Haszon I; Iványi B; Bereczki C; Papp F; Túri S
Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
Ekambaram S; Mahalingam V; Nageswaran P; Udani A; Geminiganesan S; Priyadarshini S
Indian Pediatr; 2014 May; 51(5):371-3. PubMed ID: 24953577
[TBL] [Abstract][Full Text] [Related]
15. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC;
Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
18. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
Prandota J; Jankowski A; Szozda A
Pol Tyg Lek; 1993 May 17-31; 48(20-22):455-9. PubMed ID: 8170809
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
[TBL] [Abstract][Full Text] [Related]
20. Difficult-to-treat nephrotic syndrome: management and outcome.
Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]